<SEC-DOCUMENT>0001562180-17-002240-index.html : 20170608
<SEC-HEADER>0001562180-17-002240.hdr.sgml : 20170608
<ACCEPTANCE-DATETIME>20170608193830
ACCESSION NUMBER:		0001562180-17-002240
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170607
FILED AS OF DATE:		20170608
DATE AS OF CHANGE:		20170608

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sage Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001597553
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		215 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-299-8380

	MAIL ADDRESS:	
		STREET 1:		215 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			PAUL STEVEN M
		CENTRAL INDEX KEY:			0001237564

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36544
		FILM NUMBER:		17901294

	MAIL ADDRESS:	
		STREET 1:		C/O ELI LITTY & CO
		STREET 2:		LIIY CORPORATE CENTER DC 1093
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primarydocument.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primarydocument.html

Document 1 - RAW XML: primarydocument.xml

</DOCUMENT>
</SEC-DOCUMENT>